 |
Tacrolimus |
|---|---|
| Trade Name | |
| Orphan Indication | Prophylaxis of organ rejection in patients receiving allogeneic kidney transplant |
| USA Market Approval | USA |
| USA Designation Date | 2013-12-20 00:00:00 |
| Sponsor | Veloxis Pharmaceuticals, Inc.;499 Thornall Street, 3rd Floor;Edison, NJ, 08837 |
